Biosimilar Biologics

Conditions
Medications
Orthopedic

Premier - Local Rheumatologist

Dr. Ross Petty

Rheumatologist

Vancouver, BC

Dr. Kimberly Morishita

Rheumatologist

Vancouver, BC

Dr. Diane Lacaille

Rheumatologist

Vancouver, BC

Dr. Jolanda Cibere

Rheumatologist

Vancouver, BC

Biosimilar Biologics

When the patent of an originator expires, other manufacturers are allowed to make a biosimilar version of the medicine. A biosimilar has similar effectiveness, safety, and quality and delivers the same therapeutic benefits to patients as its originator. 4
Knowledge is Power.
Open
True/False - Quiz: Do You Understand Biosimilars for the Treatment of RA?

Quiz: Do You Understand Biosimilars for the Treatment of RA?

Test your knowledge by answering the following questions:

Questions

True

False

0

Joint swelling is a symptom of rheumatoid arthritis.

Explanation:

Symptoms of rheumatoid arthritis include joint pain, swelling and stiffness.

1

Rheumatoid arthritis usually only attacks a few joints in the long-term.

Explanation:

At first, rheumatoid arthritis usually only attacks a few joints, but over time it affects more.

2

Early treatment may actually make rheumatoid arthritis go into remission.

Explanation:

Early treatment is important as it can make the disease more likely to go into remission.

3

The inflammation from rheumatoid arthritis may be painful, but it won't cause permanent damage to the joints.

Explanation:

Unlike some other types of arthritis, the chronic swelling from RA can cause permanent damage to the joints.

4

Biologics are not considered an effective treatment for rheumatoid arthritis.

Explanation:

Rheumatoid arthritis treatments include disease modifying anti-rheumatic drugs (DMARDs), nonsteroidal anti-inflammatory medications (NSAIDs), analgesics (painkillers) and biologics (medications produced from living organisms or components of living organisms).

What are biosimilar biologics?

When the patent of an originator expires, other manufacturers are allowed to make a biosimilar version of the medicine. A biosimilar has similar effectiveness, safety, and quality and delivers the same therapeutic benefits to patients as its originator.

They are typically prescribed to inflammatory arthritis patients by a rheumatologist.